Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea. - Wikidata - wikimedia - TriplyDB

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

http://www.wikidata.org/entity/Q37425698

about

KASL clinical practice guidelines: management of chronic hepatitis B A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels.Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia.Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?Virologic response and safety of tenofovir versus entecavir in treatment-naïve chronic Hepatitis B patients Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B.Randomized trial of entecavir plus adefovir in patients with lamivudine-resistant chronic hepatitis B who show suboptimal response to lamivudine plus adefovir KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial.Treatment strategies using adefovir dipivoxil for individuals with lamivudine-resistant chronic hepatitis B.Lamivudine therapy for korean children with chronic hepatitis B Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia.Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study).Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on.Prediction of risk for hepatocellular carcinoma by response of serum α-fetoprotein to entecavir therapy.Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients.Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response.Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors.Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load.Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B.Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B.Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis.Comparison of two immunoassays for quantification of hepatitis B surface antigen in Chinese patients with concomitant hepatitis B surface antigen and hepatitis B surface antibodies.Clinical implications of the titer of serum hepatitis B surface antigen during the natural history of hepatitis B virus infection.Epidemiological and genotypic profile of hepatitis B virus infection in Northern Portugal.Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.No associations of polymorphisms in ADPRT with hepatitis B virus clearance and hepatocellular carcinoma occurrence in a Korean population.Large-scale surveillance study of the safety and effectiveness of entecavir in Korean patients with chronic hepatitis B.Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.Growing attention to an old marker, hepatitis B surface antigen, in the natural history of chronic hepatitis B.

P2860

Q26752475-7065E99D-81B5-40B1-9CE3-919A79F48E3C Q33853195-16FEB52B-D33A-41D7-BD50-09D9A0EB3E7A Q33855801-400B999D-86B3-43D3-86B3-DF457C24EA2C Q33865899-9C38EA59-A70F-4C87-B2B2-AA709A3069A0 Q34459368-27A14DEB-579D-48A0-9A58-B8D04AE865DB Q34779745-0F7EBF4C-1854-49AE-924B-88C86B0FED77 Q35681979-D3C15B79-1569-4279-9420-4C96ABF9564D Q35876187-B8812F05-FBD4-41B1-A4C0-3DCBD8FBAFA0 Q35890599-416DB760-F46B-4CDB-BBC1-D275BC4C4856 Q36018658-2A902BE2-E258-4282-97E0-7B3FD7ECF5CA Q36153966-243441BA-5E96-4261-9DA6-9730A9F40C08 Q36241726-47F8B22F-E1E9-43A7-8C98-A5D2F8B14FA3 Q36254363-00D2E3F7-05ED-4ADE-AD3D-AA4D481CF2D6 Q36492636-25F700AD-253E-490D-B7E8-A50D914C1B49 Q37065689-C02AC99B-33CE-4CDE-8BC8-3DEC1977A2AE Q37334120-60370358-AE52-44E9-A24C-CDE53BBC43CB Q37444284-B426A209-C567-4916-8A04-644D4C006D0E Q37577719-FCC5F035-FCDC-40ED-9284-2AF8AB6BDD66 Q37600575-665F4F36-C568-4708-8D24-964F74FC7AC2 Q37606534-9B85E92C-A36E-4F8A-8F54-9B7636341B9F Q38475751-D6975928-DC95-46EF-9233-E64FC292086F Q39036183-489ECC14-CEDF-4838-8017-8FFD003359F2 Q39243598-AF37F69E-9555-4DE8-8AA1-F804AF9E0952 Q40172883-0F6174D6-D8BA-451F-83DC-0DC2DD1A2556 Q40409098-3EF5E005-ABF8-4C8E-9D50-37FEF4A57164 Q40493686-168A1B5E-CD6C-4E6A-888A-F4F1BED361CA Q40691267-694E6BA1-D55D-4B7D-884F-DDC2C7F161CF Q41240306-9CE4E10F-3DE2-4F83-97C2-6E8C97B6BD2D Q41554633-4DDD5C6D-DB65-402A-A770-970BC512ACFE Q41930574-7D7C0132-A565-4F47-8B45-DFAB6E6FC524 Q42173543-503D2ECF-7B8F-4187-91A6-05A95AED0FBD Q42183410-6C4AF5B0-089E-4F2F-8E61-B36ADEA276BC Q42263367-79838572-FD92-4E28-8438-B2EE759FD9AC Q42792436-B0812436-99D1-48D7-9FAE-B259058272C2 Q45361333-C45F4F39-76D0-47AA-854F-AC99C1646603 Q45369514-4870F088-1AB4-468B-999A-883949827C30 Q47195767-792CC206-FEED-4361-A056-207CC48B65A8 Q51174313-CA35B7B0-8CDA-45DC-9E26-BE90C4D53954 Q55185678-CD46AA8B-0828-4491-8DF7-CEFAB3D40A6E

P2860

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

http://www.wikidata.org/entity/Q37425698

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2005

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

@en

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

@nl

type

label

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

@en

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

@nl

prefLabel

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

@en

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

@nl

P1433

Q37425698-42836624-9F72-4DA9-9DE5-C6FF4C99E546

P1476

Q37425698-0129AF6B-1397-49F5-AB58-CE5C5C3CCD11

P2093

Q37425698-2D464E2C-6862-4EAB-BF9B-4D00234B81EB

Q37425698-301B8602-657C-49BB-A73B-3996F06A0360

Q37425698-3BD59953-7E17-4CA3-861E-5925B5566D10

Q37425698-4586D588-C7FA-4664-B49E-0ADB8DADE162

Q37425698-6C43506A-5325-4D7F-847C-B51AC5FA7BE7

Q37425698-94B7E29A-DCE5-4883-9ED4-96292F77F139

Q37425698-9A65C57C-7E69-4793-968F-2F4A9486DD88

Q37425698-B307923A-26E6-40E4-9BFC-7F25A02D8843

Q37425698-D0A97B8B-60C5-4BA1-9440-1305668BA183

Q37425698-D1D58D81-56B0-4CDA-AF9F-72E79A2E79D5

P2860

Q37425698-062E291C-8712-44DF-B129-47AD87BA5DF2

Q37425698-06BC1034-D998-45E7-9B6C-79ECFEA143DA

Q37425698-166C5B97-5C55-45D9-888D-204022C58B49

Q37425698-19E28231-7DB9-4C0F-9DF5-DA1108452D31

Q37425698-1E64ABD8-293C-43E3-8D4D-36C79F5C09F5

Q37425698-2DB366F2-10DC-4F45-9C78-A6ED203493F5

Q37425698-3513C9EA-01EA-4465-8441-9F8FC7C1EA0D

Q37425698-37DB71C3-F66E-49C2-BBD1-92E6AA3B54A1

Q37425698-39498FC3-AE42-4F04-A054-129F0E04B6F6

Q37425698-3ADAB478-6789-4FAA-9661-EADCBE490A20

P304

Q37425698-A68165D3-245D-4CE1-89D7-FEAB3E43586C

P31

Q37425698-D9CA4EFD-1E53-425A-AB35-8309ACF8AB08

P356

Q37425698-087C612F-9F1C-4660-8A6F-8935DA6880FE

P433

Q37425698-74FF3754-CF9F-4711-AFC4-86651F02CD05

P478

Q37425698-1B1721DC-EA11-4182-A9AE-CDF046B23D2B

P577

Q37425698-FEBEE232-8E18-44DB-AF5E-578C7DA97F39

P5875

Q37425698-6A00030C-6389-4CF1-BB82-B3840DAD8CDF

P698

Q37425698-8D363DD7-CD63-4CFC-BAB8-53CCF822F45E

P921

Q37425698-C81DFC33-2851-40D8-AB87-A57AA5DC9B2A

P932

Q37425698-7295B8D2-F322-45FF-87DE-FC3D960FB218

P356

JKMS.2005.20.5.816

P1433

Journal of Korean Medical Science

P1476

Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea.

@en

P2093

Boo Sung Kim

http://www.w3.org/2001/XMLSchema#string

Chang Wook Kim

http://www.w3.org/2001/XMLSchema#string

Fuminaka Sugauchi

http://www.w3.org/2001/XMLSchema#string

Jeong Won Jang

http://www.w3.org/2001/XMLSchema#string

Jong Young Choi

http://www.w3.org/2001/XMLSchema#string

Masashi Mizokami

http://www.w3.org/2001/XMLSchema#string

Seiji Suzuki

http://www.w3.org/2001/XMLSchema#string

Seung Kew Yoon

http://www.w3.org/2001/XMLSchema#string

Si Hyun Bae

http://www.w3.org/2001/XMLSchema#string

Soon Woo Nam

http://www.w3.org/2001/XMLSchema#string

P2860

mtDNA polymorphism in East Asian Populations, with special reference to the peopling of Japan

Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product.

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America.

Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China.

The prognosis of liver cirrhosis in recent years in Korea.

Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.

Natural history and control of perinatally acquired hepatitis B virus infection.

Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease.

Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region.

P304

816-820

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3346/JKMS.2005.20.5.816

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7542503

http://www.w3.org/2001/XMLSchema#string

P698

16224156

http://www.w3.org/2001/XMLSchema#string

P921

P932

2779279

http://www.w3.org/2001/XMLSchema#string